Article

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia

2023-09-22

Abstract excerpt

Pharmacogenomic (PGx) testing to inform antidepressant medication selection and dosing is gaining attention from healthcare professionals, patients, and payors in Australia. However, there is often uncertainty regarding which test is most suitable for a particular patient. Here, we identified and evaluated the coverage of CYP2D6 and CYP2C19 variants in commercial antide-pressant PGx testing panels in Victoria, a l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 891c95c8-7156-5c34-825e-8809488184fc
DOI: 10.20944/preprints202309.1566.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, AustraliaDOI 10.20944/preprints202309.1566.v1Read

Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.Semantic proximity Read

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.Semantic proximity Read

Psychiatric pharmacogenomic testing in clinical practiceSemantic proximity Read

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Semantic proximity Read

Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing Panel.Semantic proximity Read

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesSemantic proximity Read

Frequencies of CYP2C19 and CYP2D6 gene variants in a German inpatient sample with mood and anxiety disorders.Semantic proximity Read

Clinical Implementation of Pharmacogenetics: More than One Gene at a TimeSemantic proximity Read

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes.Semantic proximity Read

DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.Semantic proximity Read

Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens.Semantic proximity Read

A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.Semantic proximity Read